Evidence map›Paper›PMID 29789539›Full record

ArticleCell death & disease2018

Proteasomal degradation of the histone acetyl transferase p300 contributes to beta-cell injury in a diabetes environment.

Lucie Ruiz, Tatyana Gurlo, Magalie A Ravier, Anne Wojtusciszyn, Julia Mathieu, Matthew R Brown, Christophe Broca, Gyslaine Bertrand, Peter C Butler, Aleksey V Matveyenko and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Epigenetic Regulation of Pancreas Development and Function.Advances in anatomy, embryology, and cell biology · 2024
    Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Germline or inducible knockout of p300 or CBP in skeletal muscle does not alter insulin sensitivity.American journal of physiology. Endocrinology and metabolism · 2019
    Article
  16. Melatonin in type 2 diabetes mellitus and obesity.Nature reviews. Endocrinology · 2019
    Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Lucie RuizIGF, CNRS, INSERM, University of Montpellier, Montpellier, France.
Tatyana GurloLarry L. Hillblom Islet Research Center, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
Magalie A RavierIGF, CNRS, INSERM, University of Montpellier, Montpellier, France.
Anne WojtusciszynIGF, CNRS, INSERM, University of Montpellier, Montpellier, France.
Julia MathieuIGF, CNRS, INSERM, University of Montpellier, Montpellier, France.
Matthew R BrownDepartment of Physiology and Biomedical Engineering, Mayo Clinic School of Medicine, Mayo Clinic, Rochester, MN, USA.
Christophe BrocaLaboratory of Cell Therapy for Diabetes (LTCD), Institute for Regenerative Medicine and Biotherapy (IRMB), University Hospital of Montpellier, Montpellier, France.
Gyslaine BertrandIGF, CNRS, INSERM, University of Montpellier, Montpellier, France.
Peter C ButlerLarry L. Hillblom Islet Research Center, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
Aleksey V MatveyenkoDepartment of Physiology and Biomedical Engineering, Mayo Clinic School of Medicine, Mayo Clinic, Rochester, MN, USA.
Stéphane DalleIGF, CNRS, INSERM, University of Montpellier, Montpellier, France.
Safia CostesIGF, CNRS, INSERM, University of Montpellier, Montpellier, France. safia.costes@igf.cnrs.fr.
Centre National de la Recherche Scientifique · FRMayo Clinic in Arizona · USUniversité de Montpellier · FRUniversity of California, Los Angeles · USInserm · FRInstitute for Regenerative Medicine & Biotherapy · FR

Funding

Role of IAPP in Islet Dysfunction in DiabetesR01DK059579 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BUTLER, PETER CAWOOD · 2001 to 2019
$7.5M
NIDDK NIH HHS R01 DK059579
6 · The paper itself

Abstract

In type 2 diabetes, amyloid oligomers, chronic hyperglycemia, lipotoxicity, and pro-inflammatory cytokines are detrimental to beta-cells, causing apoptosis and impaired insulin secretion. The histone acetyl transferase p300, involved in remodeling of chromatin structure by epigenetic mechanisms, is a key ubiquitous activator of the transcriptional machinery. In this study, we report that loss of p300 acetyl transferase activity and expression leads to beta-cell apoptosis, and most importantly, that stress situations known to be associated with diabetes alter p300 levels and functional integrity. We found that proteasomal degradation is the mechanism subserving p300 loss in beta-cells exposed to hyperglycemia or pro-inflammatory cytokines. We also report that melatonin, a hormone produced in the pineal gland and known to play key roles in beta-cell health, preserves p300 levels altered by these toxic conditions. Collectively, these data imply an important role for p300 in the pathophysiology of diabetes.

Indexed as

ProteolysisAcetylationAnimalsApoptosisCytokinesDiabetes MellitusE1A-Associated p300 ProteinGlucoseHistonesHumansInflammation MediatorsInsulin-Secreting CellsMaleMelatoninMice, Inbred C57BLProteasome Endopeptidase ComplexCytokinesE1A-Associated p300 ProteinEP300 protein, humanEp300 protein, mouseGlucoseHistonesInflammation MediatorsMelatoninProteasome Endopeptidase ComplexReceptors, MelatoninRNA, Messenger

Identifiers

PMID29789539
PMCPMC5964068
OpenAlexW2803482892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.